Published in Pharmacology on January 01, 1982
Characterization of rat hypothalamic corticotropin-releasing factor. Proc Natl Acad Sci U S A (1983) 1.58
Regional haemodynamic effects of depressor neuropeptides in conscious, unrestrained, Long Evans and Brattleboro rats. Br J Pharmacol (1988) 1.32
Secretion of corticotrophin releasing factor from the adrenal during splanchnic nerve stimulation in conscious calves. J Physiol (1988) 0.91
Studies of the role of endothelium-dependent nitric oxide release in the sustained vasodilator effects of corticotrophin releasing factor and sauvagine. Br J Pharmacol (1999) 0.78
Urotensin I-CRF-Urocortins: a mermaid's tail. Gen Comp Endocrinol (2009) 0.75
Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science (1981) 9.64
Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science (1973) 7.47
Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature (1983) 5.20
Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology (1983) 4.67
Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci U S A (2001) 3.23
Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci U S A (2001) 2.87
Coupling of hormonal stimulation and transcription via the cyclic AMP-responsive factor CREB is rate limited by nuclear entry of protein kinase A. Mol Cell Biol (1993) 2.79
Diversity of Conus neuropeptides. Science (1990) 2.78
Peptide neurotoxins from fish-hunting cone snails. Science (1985) 2.77
Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour. Nature (1982) 2.44
Characterization of a bipartite activator domain in transcription factor CREB. Cell (1990) 2.41
Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature (1986) 2.29
Rapid regression of uterine leiomyomas in response to daily administration of gonadotropin-releasing hormone antagonist. Fertil Steril (1993) 2.09
CRF antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat. Psychopharmacology (Berl) (1991) 2.04
Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science (1996) 1.91
Synthetic competitive antagonists of corticotropin-releasing factor: effect on ACTH secretion in the rat. Science (1984) 1.87
Chemical and biological characterization of corticotropin releasing factor. Recent Prog Horm Res (1983) 1.86
Corticotropin releasing factor produces behavioural activation in rats. Nature (1982) 1.82
Primary structure of corticotropin-releasing factor from ovine hypothalamus. Proc Natl Acad Sci U S A (1981) 1.78
Dopamine in the treatment of hypotension and shock. N Engl J Med (1966) 1.77
Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study. J Neurosci (1985) 1.77
Corticotropin releasing factor decreases postburst hyperpolarizations and excites hippocampal neurons. Science (1983) 1.77
Somatostatin. Recent Prog Horm Res (1975) 1.67
Treatment of acute colonic pseudoobstruction (Ogilvie's syndrome) with cisapride. Gastroenterology (1990) 1.67
Corticotropin-releasing factor: actions on the sympathetic nervous system and metabolism. Endocrinology (1982) 1.58
Characterization of rat hypothalamic corticotropin-releasing factor. Proc Natl Acad Sci U S A (1983) 1.58
"Medical oophorectomy" using a long-acting GNRH agonist--a possible new approach to the treatment of endometriosis. J Clin Endocrinol Metab (1982) 1.57
Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty. Life Sci (1982) 1.57
Primary structure of the ovine hypothalamic luteinizing hormone-releasing factor (LRF) (LH-hypothalamus-LRF-gas chromatography-mass spectrometry-decapeptide-Edman degradation). Proc Natl Acad Sci U S A (1972) 1.57
Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men: an approach toward the development of a male contraceptive. N Engl J Med (1981) 1.57
Corticotropin releasing factor produces increases in brain excitability and convulsive seizures in rats. Brain Res (1983) 1.55
Assay of corticotropin releasing factor. Methods Enzymol (1983) 1.53
A double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia. The Canadian Cisapride Nud Study Group. Can J Gastroenterol (1997) 1.51
Complete amino acid sequence of urotensin I, a hypotensive and corticotropin-releasing neuropeptide from Catostomus. Science (1982) 1.51
Corticotropin-releasing factor antagonist attenuates the "anxiogenic-like" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats. Psychopharmacology (Berl) (1999) 1.46
Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor. Proc Natl Acad Sci U S A (1995) 1.45
Distribution and efferent projections of corticotropin-releasing factor-like immunoreactivity in the rat amygdaloid complex. Brain Res (1986) 1.44
The effect of somatostatin analogs on secretion of growth, pancreatic, and gastrointestinal hormones in man. J Clin Endocrinol Metab (1981) 1.42
CRF2 receptor activation prevents colorectal distension induced visceral pain and spinal ERK1/2 phosphorylation in rats. Gut (2005) 1.41
Detection and purification of inhibin using antisera generated against synthetic peptide fragments. Methods Enzymol (1989) 1.38
Functional receptors for fish neuropeptide urotensin II in major rat arteries. Eur J Pharmacol (1988) 1.37
Reversed-phase high-performance liquid chromatography: preparative purification of synthetic peptides. J Chromatogr (1984) 1.37
Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction. N Engl J Med (1984) 1.35
Role of CRF in stress-related alterations of gastric and colonic motor function. Ann N Y Acad Sci (1993) 1.33
Corticotropin releasing factor-like immunoreactivity in the rat brain as revealed by a modified cobalt-glucose oxidase-diaminobenzidine method. J Comp Neurol (1987) 1.33
Transmembrane topography of nicotinic acetylcholine receptor: immunochemical tests contradict theoretical predictions based on hydrophobicity profiles. Biochemistry (1986) 1.33
In vivo corticotropin-releasing factor-induced secretion of adrenocorticotropin, beta-endorphin, and corticosterone. Endocrinology (1982) 1.32
Conotoxins. J Biol Chem (1991) 1.28
Corticotropin releasing factor (CRF): immunoreactive neurones and fibers in rat hypothalamus. Regul Pept (1982) 1.27
Purification and partial characterization of inhibin from porcine follicular fluid. Biochem Biophys Res Commun (1985) 1.27
Characterization of a teleost gonadotropin-releasing hormone. Proc Natl Acad Sci U S A (1983) 1.26
A new family of Conus peptides targeted to the nicotinic acetylcholine receptor. J Biol Chem (1995) 1.24
D-Trp8-somatostatin: an analog of somatostatin more potent than the native molecule. Biochem Biophys Res Commun (1975) 1.24
Characterization of rat hypothalamic growth hormone-releasing factor. Nature (1983) 1.24
Human pancreatic growth-hormone-releasing factor selectively stimulates growth-hormone secretion in man. Lancet (1983) 1.23
Biologic and immunologic activities and applications of somatostatin analogs. Metabolism (1978) 1.23
Conantokin-T. A gamma-carboxyglutamate containing peptide with N-methyl-d-aspartate antagonist activity. J Biol Chem (1990) 1.22
Vasoactive intestinal peptide receptor antagonist [4Cl-D-Phe6, Leu17] VIP. Am J Physiol (1986) 1.22
Expression-cloning and sequence of a cDNA encoding human growth hormone-releasing factor. Nature (1983) 1.20
Presence of a member of the Tc1-like transposon family from nematodes and Drosophila within the vasotocin gene of a primitive vertebrate, the Pacific hagfish Eptatretus stouti. Proc Natl Acad Sci U S A (1992) 1.19
Central injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks CRF- and stress-related alterations of gastric and colonic motor function. J Pharmacol Exp Ther (1997) 1.19
Corticotropin-releasing factor (CRF): central effects on mean arterial pressure and heart rate in rats. Endocrinology (1982) 1.19
A conservative approach to the management of uterine leiomyoma: pituitary desensitization by a luteinizing hormone-releasing hormone analogue. Am J Obstet Gynecol (1983) 1.19
Location of antigenic determinants on primary sequences of subunits of nicotinic acetylcholine receptor by peptide mapping. Biochemistry (1986) 1.18
Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty. J Clin Endocrinol Metab (1981) 1.17
Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. A preliminary report. N Engl J Med (1981) 1.16
Bombesin:potent effects on thermoregulation in the rat. Science (1977) 1.16
Inhibin A-subunit cDNAs from porcine ovary and human placenta. Proc Natl Acad Sci U S A (1986) 1.16
Contraction of major artery segments of rat by fish neuropeptide urotensin II. Am J Physiol (1987) 1.15
Importance of FSH-releasing protein and inhibin in erythrodifferentiation. Nature (1988) 1.15
Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and cortisol. J Clin Invest (1983) 1.14
A highly specific antiserum for arginine vasopressin. Endocrinology (1977) 1.13
Characterization of melanin-concentrating hormone from rat hypothalamus. Endocrinology (1989) 1.13
Distinct vascular actions of epidermal growth factor-urogastrone and transforming growth factor-alpha. J Pharmacol Exp Ther (1987) 1.13
[Preliminary observations on the mechanism of action of somatostatin, a hypothalamic factor inhibiting the secretion of growth hormone]. C R Acad Sci Hebd Seances Acad Sci D (1972) 1.13
Inactivation of a serotonin-gated ion channel by a polypeptide toxin from marine snails. Science (1998) 1.12
Ligand requirements of the human corticotropin-releasing factor-binding protein. Endocrinology (1995) 1.11
Stress-induced inhibition of reproductive functions: role of endogenous corticotropin-releasing factor. Science (1986) 1.11
Structure, function, and phylogeny of [Arg8]vasotocin receptors from teleost fish and toad. Proc Natl Acad Sci U S A (1994) 1.10
Neurotensin binding to extraneural and neural receptors: comparison with biological activity and structure--activity relationships. Mol Pharmacol (1980) 1.10
Evidence for local stimulation of ACTH secretion by corticotropin-releasing factor in human placenta. Nature (1987) 1.10
Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. Effects on somatic growth and skeletal maturation. N Engl J Med (1983) 1.10
Abdominal surgery-induced delayed gastric emptying in rats: role of CRF and sensory neurons. Am J Physiol (1992) 1.09
Anatomic and phylogenetic distribution of somatostatin. Metabolism (1976) 1.08
Effects of synthetic ovine corticotropin-releasing factor, glucocorticoids, catecholamines, neurohypophysial peptides, and other substances on cultured corticotropic cells. Endocrinology (1983) 1.08
Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications. N Engl J Med (1974) 1.08
Inhibition of adrenocorticotropic hormone secretion in the rat by immunoneutralization of corticotropin-releasing factor. Science (1982) 1.08
Peripheral corticotropin releasing factor (CRF) and a novel CRF1 receptor agonist, stressin1-A activate CRF1 receptor expressing cholinergic and nitrergic myenteric neurons selectively in the colon of conscious rats. Neurogastroenterol Motil (2007) 1.08
Peptide chemistry: development of high performance liquid chromatography and capillary zone electrophoresis. Biopolymers (1996) 1.07
A noncompetitive peptide inhibitor of the nicotinic acetylcholine receptor from Conus purpurascens venom. Biochemistry (1997) 1.07
Conformational studies on somatostatin and analogues. Biochemistry (1977) 1.07
Production and regulation of inhibin subunits in pituitary gonadotropes. Endocrinology (1989) 1.06
Vasopressor receptor antagonist prevents behavioural effects of vasopressin. Nature (1981) 1.06
Corticotropin-releasing factor receptors in rat forebrain: autoradiographic identification. Science (1984) 1.06
Cardiac inotropic actions of urocortin in conscious sheep. Am J Physiol (1997) 1.06
Corticotropin releasing factor (CRF) receptor antagonist blocks activating and 'anxiogenic' actions of CRF in the rat. Brain Res (1986) 1.05
Bombesin-like activity: radioimmunologic assessment in biological tissues. Life Sci (1978) 1.05
Corticotropin-releasing factor and the brain-gut motor response to stress. Can J Gastroenterol (1999) 1.05